Technetium-99m-L,L-Ethylenedicysteine Is More Effective Than Technetium-99m Diethylenetriamine Penta-acetic Acid for Excluding Obstruction in Patients With Pyelocalicinal Dilation
Objective
To evaluate the utility of diuretic dynamic renal scintigraphy (DDRS) with technetium-99m-L,L-ethylenedicysteine (99mTc-EC) in patients with indeterminate or possible false-positive results for urinary obstruction by technetium-99m diethylenetriamine penta-acetic acid (99mTc-DTPA) DDRS.
Methods
A total of 92 patients (63 male; mean age, 16.6 ± 21.25 years) were studied, with a total of 103 kidneys presenting indeterminate (20/103) or possible false-positive results for obstruction attributable to reduced renal function or severe kidney dilation (83/103) by 99mTc-DTPA DDRS (<60% of radiopharmaceutical excreted in 20 minutes—half-time clearance [T½] >15 minutes). Patients were reimaged after intravenous injection of 99mTc-EC, with dynamic images before and after furosemide administration using the same acquisition parameters applied in the previous 99mTc-DTPA study. Time interval between 99mTc-DTPA and 99mTc-EC renograms was 2-64 days. The percentage of excreted material 20 minutes after furosemide was calculated using both radiopharmaceuticals, and were statistically compared using the paired samples t test.
Results
The excretion after furosemide injection was 25.3% ± 18.2% for 99mTc-DTPA and 41.2% ± 26.1% for 99mTc-EC, with a statistically significant difference between both radiopharmaceuticals (P <.0001). Using 99mTc-EC obstruction was excluded in 36 of 103 kidneys, which excreted >60%. A total of 10 of 83 kidneys (12.0%) with an obstructive pattern by 99mTc-DTPA study turned out to be indeterminate by 99mTc-EC DDRS. There was an agreement between 99mTc-EC and 99mTc-DTPA studies in 54 of 83 kidneys with obstructive (65.1%) and in 3 of 20 (15.0%) with indeterminate patterns.
Conclusions
99mTc-EC was more effective than 99mTc-DTPA for excluding obstruction, presenting less false-positive and indeterminate results. 99mTc-EC can substitute 99mTc-DTPA to evaluate patients with urinary tract dilation.
To access this article, please choose from the options below
PII: S0090-4295(09)03120-3
doi:10.1016/j.urology.2009.12.032
© 2010 Elsevier Inc. All rights reserved.
